Amyloidogenic Properties of a D/N Mutated 12 Amino Acid Fragment of the C-Terminal Domain of the Cholesteryl-Ester Transfer Protein (CETP) by García-González, Victor & Mas-Oliva, Jaime
Int. J. Mol. Sci. 2011, 12, 2019-2035; doi:10.3390/ijms12032019 
 
International Journal of 
Molecular Sciences 
ISSN 1422-0067 
www.mdpi.com/journal/ijms 
Article 
Amyloidogenic Properties of a D/N Mutated 12 Amino Acid 
Fragment of the C-Terminal Domain of the Cholesteryl-Ester 
Transfer Protein (CETP) 
Victor Garcí a-Gonzá lez and Jaime Mas-Oliva * 
Institute of Cell Physiology, National Autonomus University of Mexico (UNAM), AP 70-243, 
04510 Mexico, D.F., Mexico; E-Mail: vgarcia@emailifc.unam.mx 
*  Author to whom correspondence should be addressed; E-Mail: jmas@ifc.unam.mx;  
Tel.: +52-55-5622-5584; Fax: +52-55-5622-5611. 
Received: 10 January 2011; in revised form: 2 March 2011 / Accepted: 14 March 2011 /  
Published: 21 March 2011 
 
Abstract:  The  cholesteryl-ester  transfer  protein  (CETP)  facilitates  the  transfer  of 
cholesterol esters and triglycerides between lipoproteins in plasma where the critical site 
for its function is situated in the C-terminal domain. Our group has previously shown that 
this domain presents conformational changes in a non-lipid environment when the mutation 
D470N is introduced. Using a series of peptides derived from this C-terminal domain, the 
present study shows that these changes favor the induction of a secondary β-structure as 
characterized  by spectroscopic analysis and  fluorescence techniques. From this type of 
secondary  structure,  the  formation  of  peptide  aggregates  and  fibrillar  structures  with 
amyloid  characteristics  induced  cytotoxicity  in  microglial  cells  in  culture.  These 
supramolecular  structures  promote  cell  cytotoxicity  through  the  formation  of  reactive 
oxygen  species  (ROS)  and  change  the  balance  of  a  series  of  proteins  that  control  the 
process  of  endocytosis,  similar  to  that  observed  when  β-amyloid  fibrils  are 
employed.Therefore, a fine balance between the highly dynamic secondary structure of the  
C-terminal domain of CETP, the net charge, and the physicochemical characteristics of the 
surrounding microenvironment define the type of secondary structure acquired. Changes in 
this balance might favor misfolding in this region, which would alter the lipid transfer 
capacity conducted by CETP, favoring its propensity to substitute its physiological function. 
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1. Introduction 
To date, a significant number of diseases caused by the aggregation of misfolded proteins have been 
described.  Of  these,  approximately  40  diseases  present  amyloid  properties  associated  with  the 
extracellular and intracellular deposition of peptides and proteins [1]. However, self-assembly into 
fibrillar structures is not a feature restricted to a small group of peptides and proteins with specific 
patterns in their amino acid sequence or three-dimensional structure, since in the past ten years several 
peptide sequences have been found not to be related to disease despite their ability to form amyloid 
structures. The adaptation of specific cellular processes coupled to the formation of amyloids has also 
been found; for instance, during the polymerization of melanin precursor molecules in melanocytes [2]. 
Therefore, nowadays the formation of amyloid structures has been considered a property that may be 
generic to many polypeptide chains and in many cases directly related to function [3]. 
For  several  years,  our  laboratory  has  been  interested  in  the  study  of  the  relationship  between 
structure and function of proteins involved in lipid binding and transport. Secondary to changes found 
in the secondary structure of specific regions of several of these proteins such as apolipoprotein C–I, 
we  have  proposed  the  possibility  that  these  regions  respond  to  specific  changes  in  the 
microenvironment  that  surrounds  them,  and  through  specific  disorder-to-order  transitions  these 
changes act as molecular switches that trigger function [4–6]. 
The  cholesteryl-ester  transfer  protein  (CETP)  promotes  the  transfer  of  cholesterol  esters  and 
triglycerides between lipoproteins, mainly directing the cholesterol flow from high density lipoprotein 
(HDL) to low and very low density lipoproteins (LDL and VLDL). In this regard, extensive studies on 
genetic polymorphisms and CETP deficiencies suggest a direct relationship between its activity and 
cardiovascular disease [7]. Site specific mutagenesis studies have shown that the domain located in the 
C-terminus  (E465-S476),  structured  as  an  amphipathic  α-helix,  corresponds  to  a  key  region  in  lipid 
transfer (Figure 1) [8–10]. During the structural characterization of this domain, we have found that 
disruption of the H466-D470 salt bridge across the D470N mutation causes the loss of native structure, 
due in part to the change of the negatively charged carboxylate group of D for the amide group in N 
(Figure 1) [8]. 
Three-dimensional  structure  resolution  has  provided  a  solid  basis  for  the  proposal  that  CETP 
operates through a carrier mechanism of lipid transfer [11]. Nevertheless, studies from our laboratory 
suggest that the lipid transfer process can be also directly related to the formation of a lipid micellar 
system where conservation of the α-helical structure of this region is critical for the process [12]. 
Therefore, this work focused on the 12 residues of the C-terminal domain of CETP, and the structure 
and function of two peptides derived from this site, the native sequence named helix-X and a peptide 
with the mutation D470N appointed helix-Z (Figure 1), were characterized. Employing helix-Z as an 
example of hydrogen bonding disturbance has allowed us to demonstrate a conformational change of 
this region from an α-helix to a β-sheet. Ongoing experiments employing CETPI, an isoform of CETP Int. J. Mol. Sci. 2011, 12                       
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that lacks the normal C-terminal domain and instead presents a new carboxy-end mainly structured as 
a  β-sheet  [13],  supports  the  fact  that  small  order-to-disorder  and/or  disorder-to-order  transitions 
supported  by  changes  in  hydrogen  bonding  might  give  proteins  an  entirely  new  physiological 
function [14]. Secondary to the formation of β-sheet structures, helix-Z—the D/N mutated 12 amino 
acid (aa) fragment of the C-terminal domain of CETP—shows the consequent formation of oligomers 
and amyloid-like fibril structures that in turn cause cytotoxic effects similar to those exercised by the  
β-amyloid peptide. 
2. Results  
2.1. Conformational Changes in the C-Terminal Domain of CETP 
Although  previous  studies  performed  by  our  group  have  demonstrated  the  key  role  of  the  
C-terminal domain of CETP during the process of lipid transfer when holding an α-helix conformation 
(residues E465-S476) [8,13], it has not been determined yet whether this domain presents the ability to 
undergo  conformational  changes.  Therefore,  in  order  to  investigate  if  this  domain  might  undergo 
conformational changes by modifying the physicochemical properties of the surrounding media, two 
peptides were synthesized: the native C-terminal peptide called helix-X, and a second one containing 
the mutation D470N and named helix-Z (Figure 1). 
Figure 1. Structural representation of the C-terminal region of cholesteryl-ester transfer 
protein (CETP), showing the sequences of helix-X and helix-Z. The H466-D470 salt bridge 
and the hydrophobic cluster are shown. The structure was obtained from the Protein Data 
Bank, access code: 2obd.  
 
 
Helix-X and helix-Z were incubated in water in a pH range of 3.8–9.5 and studied by circular 
dichroism (CD) spectroscopy, in parallel. The secondary structure of helix-X was consistent with the 
presence of a disordered state over the whole range of pH values tested (Figure 2A). In contrast, 
CD spectra of helix-Z showed a pH specific response with minimum shift signals from 219 nm to 
201 nm,  which  is  associated  with  an  increase  in  ellipticity  indicative  of  the  formation  of  β-type Int. J. Mol. Sci. 2011, 12                       
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secondary structures (Figure 2B). This spectrum was only found in a pH range of 7–8, reaching the 
highest value at pH 7.2 (Figure 2B insert). 
Moreover, through the use of thioflavin-T (ThT) fluorescence assays, an increase in the emission 
spectrum of helix-Z with a maximum signal near 482 nm was observed (Figure 2C). Also, by testing 
with  a  Congo  red-shift  assay,  the  characteristic  birefringence  change  observed  in  the  presence  of  
β-structures with a maximum signal close to 540 nm was determined (Figure 2D). Therefore, these 
assays  confirm  the  possibility  that  under  specific  conditions  the  C-terminal  domain  of  CETP  can 
acquire a secondary structure consistent with the formation of a β-structure.  
Figure 2. Circular dichroism (CD) spectra of helix-X (A) and helix-Z (B) in a pH range of 
3.8–9.5. Inset in (B) shows ellipticity values at 219 nm; (C) Fluorescence assay coupled to 
ThT, showing a characteristic peak at 482 nm; (D) Birefringence changes of Congo red  
(Δ absorbance) at different incubation times. The peptide concentration used in all CD assays 
was 200 µ g/mL, for ThT assays was 50 µ g/mL, and for Congo red assays 180 µ g/mL. 
 
 
During the evaluation of the stability of helix-Z through temperature-induced unfolding CD assays 
(4–90  ° C),  only  temperatures  close  to  65  °C   were  found  to  induce  significant  loss  in  its  β-type 
secondary structure, suggesting high stability. The presence of an isodichroic point near 211 nm in the 
obtained spectra is associated with the presence of only two conformational states (Figure 3). These 
experiments, together with the fact that helix-Z keeps its characteristic CD profile consistent with a  
β-strand under a range of high ionic strength solutions (up to 2.4 M NaCl, data not shown), show that 
the  acquired  β-structure  is  not  determined  by  long-range  electrostatic  interactions,  but  rather  by 
stronger inter- and intra-chain interactions such as hydrogen bonds. Int. J. Mol. Sci. 2011, 12                       
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Figure 3. Temperature-induced unfolding of helix-Z. CD spectra were obtained from 4 to 
90 ° C. Inset shows ellipticity values at 219 nm (β-structure signal). The concentration of 
helix-Z employed was 200 µ g/mL. 
 
Another  set  of  experiments,  where  both  helix-X  and  helix-Z  were  incubated  in  a  hydrophobic 
environment composed of sodium dodecyl sulfate (SDS) micelles, shows that both peptides acquire 
and  maintain  an  α-helical  conformation  (Figure  4A,B).  This  transition  was  monitored  in  parallel 
following fluorescence coupled to ThT (Figure 4C) and the change in absorbance of peptide bonds at 
205  nm  (Figure  4D).  Our  results  suggest  that  the  interaction  within  a  hydrophilic/hydrophobic 
interface  may  be  the  key  parameter  to  maintain  both  peptides  in  an  α-helix  conformation;  more 
importantly, in the case of helix-Z, this is a key feature to avoid the formation of a β-structure.  
2.2. D470N Mutation in the C-Terminal Domain of CETP Induces Amyloid Fibril Formation 
In order to extend our structural analysis and considering that an increase in β-signal is not a direct 
indication of the formation of amyloid fibrils, peptide samples were analyzed by transmission electron 
microscopy (TEM). Throughout the pH-range evaluated (4–9), helix-X samples did not form any kind 
of  structured  material,  which  correlates  well  with  previous  results  in  which  helix-X  remains  in  a  
non-ordered state (Figure 5A). In contrast, when helix-Z samples were analyzed, even from the first 
sample without incubation (time 0), small oligomers were clearly identified (Figure 5B,C). It was only 
after 1 h of incubation that protofilament formation was observed (Figure 5D).  
Incubation of helix-Z for 6 h with stirring (200 rpm) was the condition that identified a mixture of 
oligomeric structures, protofilaments, and mature fibrils in some areas (Figure 5E). Samples analyzed 
after  an  incubation  time  of  72  and  120  h  at  37 ° C  clearly  showed  mature  fibrils  with  high 
morphological  similarities  to  β-amyloid  samples  (Figure  5F,G).  At  this  stage,  it  is  interesting  to 
mention  that  although  the  formation  of  fibrils  from  pH  4–9  was  evaluated,  aggregates  and  fibril 
formation were only observed at pH 7–8, which correlates well with the presence of β-structures at this 
pH range when monitored by spectrophotometric techniques.  Int. J. Mol. Sci. 2011, 12                       
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Figure 4. The effect of SDS on the secondary structure of peptides monitored by CD.  
(A) helix-X; (B) Helix-Z; (C) ThT fluorescence at 482 nm; (D) Absorbance at 205 nm. The 
peptide concentration used in all CD assays was 200 µ g/mL. For ThT assays was 50 µ g/mL 
and for absorbance assays 180 µ g/mL. 
 
 
2.3. Cytotoxic Effects Associated with Helix-Z 
Taking into account previous studies from several laboratories where microglia and macrophages 
were employed in the characterization of the cytotoxic effects of the β-amyloid peptide [15–17], when 
microglial cells were exposed to a gradual increase in concentrations of both peptides, only helix-Z 
was able to significantly reduce cell viability as measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium  bromide  (MTT)  reduction  assay  (Figure  6).  It  is  interesting  to  observe  that 
independently  of  the  incubation  time  used  for  both  peptides  in  solution  (0,  6,  120  h)  the  lowest 
concentration employed for helix-Z (1.7 µ M) shows an important reduction in cell viability that is 
maintained up to 56 µM (Figure 6A–C). At this stage it is important to mention that 0 time actually 
corresponds to the time employed to place both peptides, first in solution and second into the cell 
culture plate. This procedure takes approximately 15 min, enough time to apparently produce peptide 
oligomers as shown in Figure 5B–C. Because cell viability is maintained close to 50% independently 
of the concentration of helix-Z or the time of the incubation needed for the formation of amyloid 
structures, our experiments indicate that helix-Z in the form of oligomers seem to be the highest toxic 
form for this peptide. Whether or not mature fibrils are also responsible for cell toxicity after the 
incubation of helix-Z for 120 h, will have to be elucidated in experiments where under these conditions Int. J. Mol. Sci. 2011, 12                       
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the presence of small amounts of oligomers can be ruled out. At this stage it is interesting to mention 
that while helix-Z oligomers formed at pH 7.2 are cytotoxic, amorphous aggregates of the β-amyloid 
peptide  obtained  at  the  same  pH  do  not  present  the  ability  to  damage  microglial  cells  in  culture 
(Figure 1 supplementary data). Changes found in cell morphology are possibly related to the presence 
of a cellular stress condition as described by our group when studying the β-amyloid peptide [17] 
(Figure 6D). It is noteworthy that the MTT assay is also an indicator of oxidative stress and changes in 
the vesicular trafficking of cells [18,19]. 
Figure 5. Ultrastructural analysis of peptides by transmission electron microscopy (TEM); 
(A) Helix-X at 48 h of incubation at 37° C; (B) Helix-Z at 0 h of incubation; (C) Helix-Z at 
0.5  h  of  incubation;  (D)  Formation  of  helix-Z  protofilaments  at  1.0  h  of  incubation; 
(E) Helix-Z  under  constant  agitation  at  6.0 h  of  incubation;  (F)  Helix-Z  under  constant 
agitation  and  48  h  of  incubation;  (G)  Helix-Z  under  constant  agitation  at  120  h  of 
incubation. Solid arrows indicate oligomeric structures, open arrows show protofibrils and 
amyloid fibrils. The concentration of peptide used in all conditions was 60 µ g/mL. Bar 
indicates 200 nm. 
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Figure 6. Cytotoxic effects in microglia associated with the exposure of helix-X and helix-Z. 
(A) Cell viability determined by MTT for cells treated with peptide previously incubated 
0.5 h at 37 ° C; (B) Cells treated with peptide previously incubated 6 h at 37 °C ; (C) Cells 
treated with peptide previously incubated 120 h at 37 ° C; (D) Light microscopy showing 
microglia treated with both peptides (56 µ M) previously incubated 120 h at 37 °C .  
 Int. J. Mol. Sci. 2011, 12                       
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2.4. Endocytic Protein Expression 
After an incubation period of 120 h at 37 °C  (condition at which mature fibrils are obtained with 
helix-Z)  microglial  cells  were  treated  for  20  h  with  increasing  concentrations  of  peptides.  The 
experiment was focused on assessing the expression levels of proteins such as β-adaptin, eps 15, and 
clathrin assembly lymphoid myeloid leukemia (CALM). Cells exposed to helix-Z showed differential 
expression of some of these endocytic proteins, in contrast to experiments performed with helix-X in 
which no changes were found. While the expression of proteins such as eps 15 was held constant,  
β-adaptin protein expression decreased with respect to exposure to increasing concentrations of helix-Z 
(Figure 7A). In contrast, CALM protein expression increased with respect to the concentration of 
helix-Z  (Figure  7B).  These  results,  as  shown  previously  by  us,  correlate  well  with  the  β-amyloid 
peptide (A25–35) experiments that were employed under the same conditions as used here with helix-Z 
(Figure 1 supplementary data). 
Figure 7. Endocytic protein expression in microglial cells treated with helix-X and helix-Z. 
Both peptides were previously incubated 120 h at 37 ° C. (A) Western blot analysis of 
eps 15 and β–adaptin; (B) Western blot analysis of clathrin assembly lymphoid myeloid 
leukemia (CALM) protein. β-actin was used as loading control. 
 
3. Discussion 
During  the  search  for  factors  that  might  explain  the  formation  of  a  β-structure  in  helix-Z,  we 
propose that this structural feature is not determined by parameters such as the hydrophobic moment 
(µ H) or the mean hydrophobicity, since differences in values with respect to helix-X are minimal 
(Table 1). However, we found that helix-Z presents a β-sheet structure, only when it presents a net 
charge close to −1 in the pH range of 7–8. In contrast, helix-X with a net charge closer to −2 remains in 
a non-structured state (Table 2). Int. J. Mol. Sci. 2011, 12                       
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Table 1. Physicochemical parameters of peptides. 
Parameter  helix-X  helix-Z  Aβ1–42  Aβ25–35 
MW (Da)  1399.8  1399.6  4514  1060.3 
Isoelectric point  4.17  5.13  5.21  8.75 
Hydrophobicity (kcal/mol)  0.27  0.28  0.21  0.37 
μH (kcal/mol)  0.41  0.41  0.08  0.03 
Table 2. Net charge distribution of peptides as a function of pH. 
pH  helix-X  helix-Z  Aβ1–42  Aβ25–35 
4  0.07  0.65  3.17  1.02 
4.5  −0.47  0.34  1.55  1.01 
5  −0.87  0.06  0.38  1.00 
5.5  −1.16  −0.18  −0.49  1.00 
6  −1.47  −0.48  −1.42  0.99 
6.5  −1.75  −0.75  −2.25  0.99 
7  −1.91  −0.91  −2.72  0.99 
7.5  −1.97  −0.97  −2.92  0.99 
8  −2.00  −1.01  −3.01  0.97 
8.5  −2.06  −1.06  −3.1  0.93 
9  −2.16  −1.17  −3.32  0.79 
9.5  −2.39  −1.39  −3.81  0.52 
In this sense, there are reports that show a higher propensity to form β-structures when a low net 
charge and a high hydrophobicity are present in the peptide sequence, conditions that promote amyloid 
fibril formation [20–22]. Considering these factors, Lopez de la Paz et al. [23] have reported that 
peptide sequences are capable of forming fibrils only when they present a net charge of +1 or −1 and 
distances between charges are maximized, allowing fibrillogenesis in an orderly form as observed with 
region 25–35 of the β-amyloid peptide (Table 2). This phenomenon has been proposed as a key feature 
in molecular evolution preventing the occurrence of misfolding phenomena [24]. Also, there is strong 
evidence that intrinsically disordered proteins maintain  a high  net  charge  as  a  strategy to prevent 
aggregation [25]. Therefore, net charge may be the factor that triggers the orderly fibril formation 
shown by helix-Z. It is considered to be a two-stage process with a lag period related to the formation 
of aggregates and nucleation centers and a second stage related to fast spreading [26]. 
Taking  into  account  the  spectrophotometric  results,  the  evidence  of  fibrillar  structures  and  the 
physicochemical properties of helix-Z such as μH, hydrophobicity, and a net charge of −0.96 at pH 7.2, 
we present a model for the amino acid residue disposition within the β-strand (Figure 8A). Since D470N 
showed  the  loss  of  one  negative  charge,  the  hydrophobic  cluster  (L467LVNFL472)  maintained  a  
β-conformation  through  hydrophobic  interactions.  It  is  also  important  to  consider  that  along  the 
sequence, there are asparagine and glutamine residues that are considered as inducers of β-structures 
and therefore allow the stacking of polypeptide chains [27]. Helix-X does not show this phenomenon, 
largely due  to an  electrostatic repulsion  at  Asp-470 that prevents the  formation of a  hydrophobic 
cluster that maintains the peptide under an extended state (Figure 8B). Int. J. Mol. Sci. 2011, 12                       
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Figure 8. Model of an antiparallel β-strand in helix-Z. (A) The charge of each residue is 
determined considering  a  pH  of  7.2.  N  and  C  terminal  groups  are loaded  allowing  an 
electrostatic attraction between peptide chains. Shaded regions identify the hydrophobic 
cluster L467LVNFL472, as well as N and Q residues; (B) Helix-X does not form a β-strand 
structure due to the electrostatic repulsion between D residues. 
 
On the other hand, it is surprising that helix-X is maintained as an α-helix in the crystallographic 
data shown for CETP due to its µH  value of 0.41 kcal/mol, factor B value, and relative freedom from 
the main body of the protein. In this regard, peptide sequences showing the potential for intrinsic 
disorder  and  domains  with  high  factor-B  values  are  associated  with  a  high  thermal  vibration  of 
individual atoms and therefore present high intramolecular flexibility [28]. Although helix-X presents 
an α-helix profile in the crystal structure of CETP, when held outside a lipid environment it might 
adopt a disordered structure with the possibility that this region might undergo disorder-to-order and/or 
order-to-disorder  transitions.  This  type  of  transition  must  probably  present  a  different  equilibrium 
when changes like the one found in helix-Z is introduced to this region since the formation of a β-sheet 
might not be reversible. 
Oil-water interfaces also present the ability to promote the stabilization of the secondary structure 
of peptides  believed  to  the  due  to  hydrogen  bonding  and  a  reduction  of  the  energetic  cost  of 
partitioning [29]. As previously suggested for the bee venom peptide mellitin, this peptide is largely 
unstructured when placed in solution, but highly structured as an amphipathic α-helix when partitioned 
into unilamellar phospholipid vesicles [30]. While the free energy reduction per residue observed for the 
folding of mellitin in a membrane interface is almost 0.4 kcal mol
−1 consistent with the formation of 
hydrogen bonding, values close to 0.6 kcal mol
−1 have been also shown for β-sheet forming peptides [30].  
Studies  performed  by  our  group  using  β-amyloid  fibrils  as  a  natural  ligand  for  the  scavenger 
receptor (SR), an association directly related to the development of oxidative stress, have shown changes 
in the expression of several adaptor proteins involved in the endocytic machinery of macrophages and 
microglia [17,31]. Proteins α-, β-, μ-, and σ-adaptins integrate into the AP2 adaptor complex, a key 
component  in  the  initial  stages  of  endocytosis  [5].  Within  the  mechanism  of  clathrin-mediated 
endocytosis  of  the  SR,  more  than  30  proteins  have  been  described,  many  of  which  are  adaptor 
molecules involved in the formation of coated pits. In addition to clathrin, proteins such as CALM, 
epsin, dynamin, amphiphysin, and eps 15 also play an important role in this process [32]. Int. J. Mol. Sci. 2011, 12                       
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The present results show that when microglial cells are exposed to helix-Z, peptide oligomers first 
and fibrillar species next, are the leading cause for the registered cytotoxic phenomena. Moreover, high 
concentrations  of  helix-Z  fibrils  inhibit  β-adaptin  expression.  With  the  decline  of  β-adaptin,  the 
increased expression observed for CALM could function as a cellular compensatory mechanism for 
endocytic function. In this sense, the ANTH domain (AP180 N-Terminal Homology) located in the 
first 300 residues of CALM allows interaction with PtdIns(4,5)P2 [33], functioning as a bridge between 
the plasma membrane clathrin-coated pit and other adaptor proteins [34]. Taking into account that a 
similar response in β-adaptin and CALM was found in this study when cells were exposed to helix-Z 
fibrils, possibly this condition may be associated with a phenomenon found in cells that come in 
contact with toxic peptide oligomers and/or amyloid fibrils. 
4. Experimental Section 
4.1. Materials 
All cell culture reagents were purchased from Gibco-Invitrogen (Carlsbard, CA, USA), while tissue 
culture dishes and other plasticware were obtained from Nulgene Nunc (Rochester, NY, USA). Salts 
and buffers were purchased from Baker. Tert-butyl hydroperoxide (TBH), ThT, Congo-red, SDS and 
MTT were obtained from Sigma (St. Louis, MO, USA). Antibodies used in CALM, -adaptin, and 
eps 15 protein detection as well as goat secondary antibodies were from Santa Cruz Biotechnoloy Inc. 
4.2. Peptide Synthesis and Preparation 
Based on the function of the C-terminal of CETP, two peptides were synthesized: one named helix-X 
that corresponds to the native peptide, and the second one named helix-Z containing the mutation 
D470N. Lyophilized peptides were dissolved in ammonium carbonate buffer (pH 9.5) to a concentration 
of 1 mg/mL. From this solution a further 1:5 dilution was carried out. To evaluate the structure at 
pH 3.8 and 4.8, a sodium acetate buffer was used; pH 6.3 and 7.2, a sodium phosphate buffer was 
used, and at pH 8.6 and 9.5, an ammonium carbonate buffer was employed.  
Fragment A25–35 (β-amyloid) was employed as a reference molecule for the cytotoxicity assays. 
Experiments performed with -amyloid were carried out at two pH conditions using a phosphate buffer 
(pH 7.2) and ultrapure water (pH 5.5), both with the same peptide concentration (1.5 mg/mL). All 
buffers were used at 50 mM, and solutions were filtered through 0.22 µm membrane filters before use. 
Purity of peptides was greater than 98% (GenScript Corp., Piscataway, NJ, USA). Their identity 
and  purity  were  confirmed  by  mass  spectrometry  and  HPLC  analysis  (data  not  shown).  Protein 
concentration was determined by peptide bond absorption at 205 nm. 
4.3. Circular Dichroism Spectroscopy 
Far-UV CD spectra were recorded on an Aviv 62DS spectropolarimeter in a 0.1 cm quartz cell, 
using an average time of 2.5 s and a step size of 0.5 nm. CD results are reported as mean molar 
ellipticity (Θ, deg cm
2 dmol
−1) considering the baseline correction. For the pH studies, CD spectra 
were obtained from pH 3.8 to −9.5. Peptide unfolding induced by temperature was monitored by CD 
measurements over a temperature range of 4 to 90 ° C.  Int. J. Mol. Sci. 2011, 12                       
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4.4. Congo Red Spectroscopy and Thioflavin T Fluorescence 
Congo red assays were performed based in the protocol designed by Klunk et al. [35]. Employing 
10.6 µM  Congo red and 180 µ g/mL of peptide, the absorbance was measured every 2 nm using a 
Perkin Elmer UV/Vis Lambda 2S spectrophotometer scanning from 360 to −700 nm. Peptide spectra 
were corrected by subtracting the corresponding buffer spectra obtained under identical conditions. 
Additionally, the presence of β-structures was characterized with the ThT assay. ThT fluorescence 
emission  spectra  were  registered  at  37 ° C  from  470  to  530  nm  with  an  excitation  wavelength  of 
450 nm.  A  scan  velocity  of  73  nm/min  using  an  Olis  DM45  spectrofluorimeter  was  used.  The 
concentrations of ThT and peptides were 10 µM  and 36 µM , respectively.  
4.5. Cell Culture 
EOC  cells  (mouse  microglia,  American  Type  Culture  Collection)  were  grown  in  Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum, and 20% mouse bone 
marrow, producing colony stimulating factor-1 (LADMAC) conditioned media. Penicillin (50 U/mL) 
and streptomycin (50 g/mL) were added to the media. After the initial culture, all experiments were 
performed using Opti-MEM medium without phenol red and reduced fetal serum. 
4.6. Cell Viability Assay 
Peptide  cytotoxicity  was  assessed  by  MTT  reduction  assays  in  EOC  cells  exposed  to  helix-X,  
helix-Z, and the β-amyloid peptide (Aβ25–35). Cells were seeded into 96-well plates at a density of  
1 ×  10
4 cells/well and allowed to grow to 80% confluence. Next, culture medium was replaced with 
Opti-MEM  medium.  After  2  h  under  this  condition,  cells  were  treated  with  a  series  of  gradually 
increasing  peptide  concentrations  for  20  h.  After  this  time,  30  μL  of  an  MTT  stock  solution  in  
Opti-MEM medium was added to the cultures in order to obtain a final concentration of 0.5 mg/mL. 
Formazan crystals that formed after 4 h of incubation were further dissolved by the addition of cell 
lysis buffer (20% SDS, 50% N,N-dimethylformamide, pH 3.7). After 12 h of incubation, absorbance 
was measured at 570 nm using a microplate reader. 
4.7. Western Blot Analysis 
With a plate confluence of 80%, cells were treated for 20 h with different doses of peptides. After 
this procedure, cells were washed with PBS and lysed for 45 min at 4 ° C in lysis buffer. Lysed cells 
were centrifuged at 5000 rpm for 5 min and the supernatant was recovered. Protein concentration was 
determined with the BCA protein assay (Pierce, Rockford IL, USA) and samples (14 μg/lane) from the 
total  protein  fraction  were  analyzed  by  SDS-PAGE  on  8%  gels  and  further  transferred  to  PVDF 
membranes (Millipore, Billerica, MA, USA). Membranes were blocked overnight at 4 ° C in a solution 
containing Tris-buffered saline (TBS), 1% tween-20, and 5% non-fat milk. For protein detection, the 
following primary polyclonal antibodies were used: goat anti--adaptin (1:600), CALM (1:600), and 
rabbit anti-eps 15 (1:2500). In addition, the mouse monoclonal anti -actin (1:500) was used. The 
blocked  membranes  were  incubated  with  the  primary  antibodies  for  1 h  a  37 ° C.  After  washing, 
horseradish peroxidase (HRP) conjugated secondary antibodies (1:5000) were added to the membrane Int. J. Mol. Sci. 2011, 12                       
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and were incubated for 1h at 37 °C  in blocking buffer. The secondary antibodies used were: donkey 
anti-goat  IgG  for  β-adaptin  and  CALM,  goat  anti-rabbit  IgG  for  eps 15,  and  goat  anti-mouse  for  
β-actin. Later, membranes were washed with TBS/1% tween and HRP activity was detected with the 
Immobilon Western kit (Millipore). 
4.8. Optical Microscopy 
Under the different exposures using variable concentrations of helix-X, helix-Z, and the -amyloid 
peptide  (A25–35),  EOC  cells  were  visualized  and  images  were  taken  with  an  Olympus  IX71 
microscope (100 and 400× ).  
4.9. Electron Microscopy 
Peptide samples incubated under the different conditions tested were processed using a negative 
staining technique and visualized using TEM. Samples (10 µ L) stained with uranyl acetate solution 
(2% w/v) were placed on carbon-coated copper grids (400 mesh); and after incubation for 5 min 
at 25 ° C  they  were  dried  for  10  min.  TEM  images  were  acquired  using  a  JEM-1200EX11  JEOL 
microscope (70 kV).  
5. Conclusions 
Since the mutation D470N in the C-terminal domain of CETP exemplifies the delicate balance that 
exists in the conformational changes at the secondary structure level modulated by pH and amino  
acid-charge modification, disruption of this dynamic equilibrium could lead to the formation of new 
interactions like hydrogen bonds within the hydrocarbon backbone and between side chains, which 
promote aggregation and the formation of fibril structures [36]. Although the D470N mutation (helix-Z) 
described in this investigation has not been found in nature, helix-X, the natural 12 aa segment of the  
C-terminal domain of CETP, when partitioned into water or into oil-water interfaces might present 
potential disorder-to-order and/or order-to-disorder transitions that normally are difficult to identify. 
Therefore, we have used helix-Z in order to mimic potential changes in secondary structure of helix-X 
by simply modifying hydrogen bonding that in turn might explain changes in the overall function of 
native CETP when studied in vivo.  
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Supplementary Data 
Figure  1S. Effect of pH on Aβ25–35 fibril formation. (A) Aβ25–35 incubated for 72 h at 
pH 7.2 induces the formation of amorphous aggregates; (B) Microglial cells treated with 
these  amorphous  aggregates  did  not  produce  changes  in  endocytic  protein  expression;  
(C) Incubation of Aβ25–35 for 72 h at pH 5.5 induces the formation of well-defined fibrils; 
(D) Cells treated with Aβ25–35 fibrils show changes in β-adaptin and CALM expression;  
(E) Well-defined fibrils of Aβ25–35 induce a gradual decrease in microglial cell viability. 
TEM images were obtained with a peptide concentration of 60 µ g/mL. Bars correspond 
to 200 nm. 
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